期刊文献+

10-羟基喜树碱对类风湿关节炎基质金属蛋白酶-3的影响

Effect of 10-Hydroxy-camptothecine on m RNA expression of MMP-3 in rheumatoid arthritis
原文传递
导出
摘要 目的研究10-羟基喜树碱(10-Hcdroxycamptotbecine,10-HCPT)对类风湿关节炎滑膜成纤维细胞(Rheumatoid Arthritis synovial fibroblasts,RASF)基质金属蛋白酶(matrix metalloproteinase-3,MMP3)m RNA表达的影响。方法选取北京大学人民医院2016年8月—2017年1月行全膝关节置换术或关节镜滑膜切除术的类风湿关节炎患者的关节滑膜组织,体外分离培养RASF,用不同浓度的10-HCPT及MTX(1.0、10.0μg/m L)处理RASF,分别为10-HCPT、MTX低、高浓度组,不加药物的细胞作为对照组,培养24 h后,提取细胞RNA,采用荧光定量PCR方法(RT-PCR)检测MMP3-m RNA表达。结果与对照组比较,10-HCPT及MTX高浓度组MMP 3 m RNA表达降低(P<0.01)。对比10-HCPT低浓度组,10-HCPT和MTX高浓度MMP 3 m RNA表达同时降低(P<0.01)。10-HCPT及MTX同浓度组间比较,差异无统计学意义(P>0.05)。结论 10-HCPT可抑制RASF MMP-3 m RNA表达。 Objective To observe the effect of 10-hydroxy-camptothecine(10-HCPT) on m RNA expression level of matrix metalloproteinase-3(MMP-3) in rheumatoid arthritis synovial fibroblasts(RASF). Methods Chose between August 2016 and January 2016 Beijing University People's Hospital of total knee replacement or arthroscopic synovectomy articular synovial tissue in patients with rheumatoid arthritis,RASFs were isolated from synovial tissue of RA patients and cultured in vitro,and then treated with 10-HCPT and Methotrexate(MTX) at high and low concentrations(1. 0 and 10. 0 μg/m L). RASFs without drug intervention were set up as a control group. After 24 h culture RNA was isolated. m RNA expression of MMP-3 was measured by real time PCR(RT-PCR). Results Compared with the control group,m RNA expression of MMP-3 markedly decreased in high concentration 10-HCPT and MTX groups(P〈0. 01). Compared with low concentration 10-HCPT group,m RNA expression of MMP-3 obviously decreased in high concentration 10-HCPT and MTX groups(P〈0. 01). But there was no statistical difference between 10-HCPT groups and MTX groups at the same concentration(P〉0. 05). Conclusion 10-HCPT could inhibit m RNA expression of MMP-3 in RASFs.
作者 孙贺 王燕 任丽丽 孙晓麟 王少亭 杨宏 张丽娟 张濛 SUN He;WANG Yah;REN Li - li;SUN Xiao - lin;WANG Shao - ring;YANG Hang;ZHANG Li- juan;ZHANG Meng(Department of Rheumatology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450002, Chin)
出处 《医药论坛杂志》 2018年第2期11-13,共3页 Journal of Medical Forum
基金 河南省教育厅重点科技攻关项目(14A320053)
关键词 10-羟基喜树碱 类风湿关节炎 滑膜成纤维细胞 基质金属蛋白酶-3 10- hydroxy- camptothecine Rheumatoid arthritis Synovial fibroblast Matrix metalloproteinase- 3
  • 相关文献

参考文献2

二级参考文献23

  • 1Klimiuk PA,Sierakowski S,Latosiewicz R,et al.Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histologieal variants of rheumatoid synovitis. Rheumatology (Oxford),2002,41:78-87.
  • 2Yamanaka H,Matsuda Y,Tanaka M,et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement,in patients with early rheumatoid arthritis. Arthritis Rheum,2000,43:852-858.
  • 3Cunnane G,Fitz-Gerald O,Beeton C,et al. Early joint erosions and serum levels of matrix metalloproteinases 1,matrix metalloproteinases 3,and tissue inhibitor of metalloproteinases 1 in rheumatoid athritis.Arthritis Rheum,2001,44:2263 -2274.
  • 4Ishiguro N,Ito T,Obata K,et al. Determination of stromelysin-1,72 Kda type Ⅳ collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1),and TIMP-2 in synovial fluid and serum from patients with rheumatoidarthritis .J Rheumatol, 1996,23:1599-1604.
  • 5Wolfe F,Sharp JT.Radiographic outcome of recent-onset rheumatoid arthritis:a 19-year study of radiographic progression.Arthritis Rheum,1998,41:1571-1582.
  • 6Green MJ,Gough AK,Devlin J,et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology,2003,42:83-88.
  • 7Posthumus,MD,Limburg PC,Westra J. Serum matrix metalloproteinase 3in early rheumatoid arthritis is correlated with disease activity and radiological progression. J Rheumatol,2000,27:2761-2768.
  • 8Ribbens C,Andre B,Jaspar J.Matrix mettalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis.J Rheumatol,2000,27:888-893.
  • 9Zucker S,Hymovitz M,Conner C,et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tis-sues:clinical experimental applications.Ann NY Acad Sci, 1999,878:212-227.
  • 10Okada Y.Proteinases and matrix degradation. In:Kelley WN,Ruddy S,Harris ED,eds.Textbook of rheumatology.6th ed. Philadelphia:WB Saunders,2000.55-72.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部